UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3379-3385

2015

Volltextzugriff (PDF)

Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?

Breast cancer research and treatment, 2023-06, Vol.199 (2), p.215-220

2023

Volltextzugriff (PDF)

Is Confirmatory Biopsy Still Necessary for Active Surveillance of Men With Grade Group 1 Prostate Cancer in the Era of Multiparametric MRI?

The Journal of urology, 2024-10, p.101097JU0000000000004268

2024

Volltextzugriff (PDF)

Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate‐risk to very‐high‐risk clinically localised prostate cancer

BJU international, 2019-08, Vol.124 (2), p.268-274

2019

Volltextzugriff (PDF)

Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active Surveillance

The Journal of urology, 2023-01, Vol.209 (1), p.180-186

2023

Volltextzugriff (PDF)

Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era

The Prostate, 2024-06, Vol.84 (8), p.723-730

2024

Volltextzugriff (PDF)

Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance

BJU international, 2020-06, Vol.125 (6), p.861-866

2020

Volltextzugriff (PDF)

Risk prediction tool for grade re‐classification in men with favourable‐risk prostate cancer on active surveillance

BJU international, 2017-07, Vol.120 (1), p.25-31

2017

Volltextzugriff (PDF)

Conditional Probability of Reclassification in an Active Surveillance Program for Prostate Cancer

The Journal of urology, 2015-06, Vol.193 (6), p.1950-1955

2015

Volltextzugriff (PDF)

Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery

European urology, 2016-04, Vol.69 (4), p.576-581

2016

Volltextzugriff (PDF)

Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification

Urologic oncology, 2023-11, Vol.41 (11), p.455.e1-455.e6

2023

Volltextzugriff (PDF)

106 Cumulative Cancer Location Incidence and Cancer Progression in an Active Surveillance Cohort

Journal of clinical and translational science, 2022-04, Vol.6 (s1), p.2-2

2022

Volltextzugriff (PDF)

MP17-01 HETEROGENEITY IN DETECTION RATES OF HIGHER GRADE PROSTATE CANCER BY MULTIPARAMETRIC MRI IN AN ACTIVE SURVEILLANCE COHORT

The Journal of urology, 2018-04, Vol.199 (4), p.e205-e205

2018

Volltextzugriff (PDF)

Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort

European urology, 2020-06, Vol.77 (6), p.675-682

2020

Volltextzugriff (PDF)

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer

European urology, 2019-05, Vol.75 (5), p.743-749

2019

Volltextzugriff (PDF)

MP15-08 IS PSA DENSITY OR PSA (OR NEITHER) USEFUL TO PREDICT BIOPSY RECLASSIFICATION IN ACTIVE SURVEILLANCE PATIENTS?

The Journal of urology, 2016-04, Vol.195 (4), p.e154-e155

2016

Volltextzugriff (PDF)

PD26-03 THE EFFECT OF PROSTATE VOLUME ON GRADE PROGRESSION AND TREATMENT DECISIONS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER ON ACTIVE SURVEILLANCE

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

IMPACT OF SOCIAL DISTANCING DURING THE SARS-COV-2 PANDEMIC ON THE ASSOCIATION BETWEEN VIRAL RESPIRATORY ILLNESS AND CARDIOVASCULAR-RELATED EVENTS

Chest, 2022-10, Vol.162 (4), p.A285-A285

2022

Volltextzugriff (PDF)

MP43-04 COMPARISON OF 4K SCORE, PROSTATE HEALTH INDEX, AND PSA DENSITY IN ACTIVE SURVEILLANCE

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

MP43-01 CLINICAL SIGNIFICANCE OF DETECTION OF PERINEURAL INVASION IN LOW-RISK MEN ON ACTIVE SURVEILLANCE

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

TCT-397 Comparative Outcomes of Below-the-Knee CTO vs Non-CTO Peripheral Artery Interventions From the XLPAD Registry

Journal of the American College of Cardiology, 2024-10, Vol.84 (18), p.B113-B113

2024

Volltextzugriff (PDF)

TCT-30 Comparative Outcomes of Nonstent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

Journal of the American College of Cardiology, 2024-10, Vol.84 (18), p.B111-B111

2024

Volltextzugriff (PDF)

MP38-04 BASELINE PROSTATE HEALTH INDEX RISK CATEGORY AND RISK CATEGORY CHANGES DURING ACTIVE SURVEILLANCE PREDICT GRADE RECLASSIFICATION

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

MP62-16 PROSTATE CANCER RADIOLOGICAL ESTIMATION OF CHANGE IN SEQUENTIAL EVALUATION (PRECISE) SCORING TO PREDICT CLINICAL OUTCOMES IN ACTIVE SURVEILLANCE OF PROSTATE CANCER

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

PD17-07 IS CONFIRMATORY BIOPSY STILL NECESSARY IN MEN WITH GRADE GROUP 1 PROSTATE CANCER IN THE MULTIPARAMETRIC MRI ERA?

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(103)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer

Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?

Is Confirmatory Biopsy Still Necessary for Active Surveillance of Men With Grade Group 1 Prostate Cancer in the Era of Multiparametric MRI?

Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate‐risk to very‐high‐risk clinically localised prostate cancer

Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active Surveillance

Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era

Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance

Risk prediction tool for grade re‐classification in men with favourable‐risk prostate cancer on active surveillance

Conditional Probability of Reclassification in an Active Surveillance Program for Prostate Cancer

Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery

Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification

106 Cumulative Cancer Location Incidence and Cancer Progression in an Active Surveillance Cohort

MP17-01 HETEROGENEITY IN DETECTION RATES OF HIGHER GRADE PROSTATE CANCER BY MULTIPARAMETRIC MRI IN AN ACTIVE SURVEILLANCE COHORT

Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer

MP15-08 IS PSA DENSITY OR PSA (OR NEITHER) USEFUL TO PREDICT BIOPSY RECLASSIFICATION IN ACTIVE SURVEILLANCE PATIENTS?

PD26-03 THE EFFECT OF PROSTATE VOLUME ON GRADE PROGRESSION AND TREATMENT DECISIONS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER ON ACTIVE SURVEILLANCE

IMPACT OF SOCIAL DISTANCING DURING THE SARS-COV-2 PANDEMIC ON THE ASSOCIATION BETWEEN VIRAL RESPIRATORY ILLNESS AND CARDIOVASCULAR-RELATED EVENTS

MP43-04 COMPARISON OF 4K SCORE, PROSTATE HEALTH INDEX, AND PSA DENSITY IN ACTIVE SURVEILLANCE

MP43-01 CLINICAL SIGNIFICANCE OF DETECTION OF PERINEURAL INVASION IN LOW-RISK MEN ON ACTIVE SURVEILLANCE

TCT-397 Comparative Outcomes of Below-the-Knee CTO vs Non-CTO Peripheral Artery Interventions From the XLPAD Registry

TCT-30 Comparative Outcomes of Nonstent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

MP38-04 BASELINE PROSTATE HEALTH INDEX RISK CATEGORY AND RISK CATEGORY CHANGES DURING ACTIVE SURVEILLANCE PREDICT GRADE RECLASSIFICATION

MP62-16 PROSTATE CANCER RADIOLOGICAL ESTIMATION OF CHANGE IN SEQUENTIAL EVALUATION (PRECISE) SCORING TO PREDICT CLINICAL OUTCOMES IN ACTIVE SURVEILLANCE OF PROSTATE CANCER

PD17-07 IS CONFIRMATORY BIOPSY STILL NECESSARY IN MEN WITH GRADE GROUP 1 PROSTATE CANCER IN THE MULTIPARAMETRIC MRI ERA?

Aktive Filter

Suchergebnisse filtern